International Myeloma Foundation Highlights from the 50th Annual Meeting of the American Society for Hematology (ASH) held in San Francisco, California, December 5–9, 2008.
New and updated data on the use of novel therapeutics in combination therapy in patients with newly diagnosed or relapsed/refractory multiple myeloma were presented at the 2007 meeting of the American Society of Clinical Oncology (ASCO), June 1 through 5, in Chicago, Illinois.